Effect of Dexamethasone in the Development of O1 or O4 Immunoreactive Oligodendrocyte of the Neonatal Rat
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
White matter disease (WMD) study, which underlies the subsequent progress of cerebral palsy as well as cognitive impairment of premature and/or low birth weight infants, has been focused either on the hypoxia-ischemia damage or cytokine-induced brain damage related with maternal or fetal inflammation. Also, dexamethasone (DEXA) may increase the risk of neuropsychological problem including adverse cognitive and behavioral outcome in preterm infants. Thus, we hypothesized that perinatal DEXA would damage and trigger the death of developing oligodendrocytes (OL) progenitors, and subsequently disturb myelination. In this study, DEXA was administered to neonatal rats for 3 consecutive days subcutaneously between postnatal day 1 (P1) and P3. By using immunofluorescent staining of stage specific OL progenitor markers such as O4 and O1, the morphological changes of OL progenitors were examined and the apoptosis of OL progenitors were visualized by TUNEL staining. Results depicted that relative number of O1 immunoreactive (IR) cells were less to that of O4 IR cells. Multipolar O1 IR cells with short dendritic processes were observed in both control and DEXA group at P3. In the total O1 immunoreactive cells, the relative percentages of apoptosis cells were calculated at P3 as 8.7% in control, 23.0% in DEXA group. The relative percentages of apoptosis in the total O4 immunoreactive cells were measured at P3 as 3.0% in control and 13.5% in DEXA group.OL progenitors’ apoptosis may contribute to the overall reduction of immature OLs in cerebral white matter. Therefore, specific stages of OL maturation could clinically be an important factor in determining the susceptibility to DEXA. To elucidate the disease mechanism of the white matter disease, further investigation may be needed whether OL progenitors’ decrease by the DEXA administration affects to the myelin formation as developmental stages.
Abstract
White matter disease (WMD) study, which underlies the subsequent progress of cerebral palsy as well as cognitive impairment of premature and/or low birth weight infants, has been focused either on the hypoxia-ischemia damage or cytokine-induced brain damage related with maternal or fetal inflammation. Also, dexamethasone (DEXA) may increase the risk of neuropsychological problem including adverse cognitive and behavioral outcome in preterm infants. Thus, we hypothesized that perinatal DEXA would damage and trigger the death of developing oligodendrocytes (OL) progenitors, and subsequently disturb myelination. In this study, DEXA was administered to neonatal rats for 3 consecutive days subcutaneously between postnatal day 1 (P1) and P3. By using immunofluorescent staining of stage specific OL progenitor markers such as O4 and O1, the morphological changes of OL progenitors were examined and the apoptosis of OL progenitors were visualized by TUNEL staining. Results depicted that relative number of O1 immunoreactive (IR) cells were less to that of O4 IR cells. Multipolar O1 IR cells with short dendritic processes were observed in both control and DEXA group at P3. In the total O1 immunoreactive cells, the relative percentages of apoptosis cells were calculated at P3 as 8.7% in control, 23.0% in DEXA group. The relative percentages of apoptosis in the total O4 immunoreactive cells were measured at P3 as 3.0% in control and 13.5% in DEXA group.OL progenitors’ apoptosis may contribute to the overall reduction of immature OLs in cerebral white matter. Therefore, specific stages of OL maturation could clinically be an important factor in determining the susceptibility to DEXA. To elucidate the disease mechanism of the white matter disease, further investigation may be needed whether OL progenitors’ decrease by the DEXA administration affects to the myelin formation as developmental stages.
참고문헌 (39)
- Ahlbom E, "Prenatal exposure to high levels of glucocorticoids increases the susceptibility of cerebellar granule cells to oxidative stress-induced cell death", Proc Natl Acad Sci USA, 통권 : 97, pp.14726~14730 (2000)
- Back SA, "Maturation- dependent vulnerability of oligodendrocytes to oxidative stress-induced death caused by glutathione depletion", J Neurosci, 18, pp.6241~6253 (1998)
- Back SA, "Selective vulnerability of late oligodendrocyte progenitors to hypoxia-ischemia", J Neurosci, 22, pp.455~463 (2002)
- Back SA, "Late oligodendrocyte progenitors coincide with the developmental window of vulnerability for human perinatal white matter injury", J Neurosci, 21, pp.1302~1312 (2001)
- Baud O, "Postnatal steroid treatment and brain development", Arch Dis Child Fetal Neonatal Ed, 89, pp.F96~F100 (2004)
- Baud O, "Corticosteroids in perinatal medicine: how to improve outcomes without affecting the developing brain?", Semin Fetal Neonatal Med, 12, pp.273~279 (2007)
- Benesová O, "Perinatal treatment with glucocorticoids and the risk of maldevelopment of the brain", Neuropharmacology, 28, pp.89~97 (1989)
- Bhutta AT, "Vulnerability of the developing brain. Neuronal mechanisms", Clin Perinatol, 29, pp.357~372 (2002)
- Committee on Fetus and Newborn, "Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants", Pediatrics, 109, pp.330~338 (2002)
- Craig A, "Quantitative analysis of perinatal rodent oligodendrocyte lineage progression and its correlation with human", Exp Neurol, 181, pp.231~240 (2003)
- Dammann O, "Lung and brain damage in preterm newborns. Are they related? How? Why?", Biol Neonate, 85, pp.305~313 (2004)
- Debillon T, "Intrauterine infection induces programmed cell death in rabbit periventricular white matter", Pediatr Res, 47, pp.736~742 (2000)
- Eklind S, "Bacterial endotoxin sensitizes the immature brain to hypoxic--ischaemic injury", Eur J Neurosci, 13, pp.1101~1106 (2001)
- Fern R, "Rapid ischemic cell death in immature oligodendrocytes: a fatal glutamate release feedback loop", J Neurosci, 20, pp.34~42 (2000)
- Follett PL, "NBQX attenuates excitotoxic injury in developing white matter", J Neurosci, 20, pp.9235~9241 (2000)
- Gard AL, "Oligodendrocyte progenitors isolated directly from developing telencephalon at a specific phenotypic stage: myelinogenic potential in a defined environment", Development, 106, pp.119~132 (1989)
- Grier DG, "Management of bronchopulmonary dysplasia in infants: guidelines for corticosteroid use", Drugs, 65, pp.15~29 (2005)
- Gu C, "Oligodendrocyte apoptosis mediated by caspase activation", J Neurosci, 19, pp.3043~3049 (1999)
- Gumbinas M, "The effects of corticosteroids on myelination of the developing rat brain", Biol Neonate, 22, pp.355~366 (1973)
- Hagberg H, "Models of white matter injury: comparison of infectious, hypoxic-ischemic, and excitotoxic insults", Ment Retard Dev Disabil Res Rev, 8, pp.30~38 (2002)
- Hauser J, "Effects of prenatal dexamethasone treatment on physical growth, pituitary-adrenal hormones, and performance of motor, motivational, and cognitive tasks in juvenile and adolescent common marmoset monkeys", Endocrinology, 149, pp.6343~6355 (2008)
- Kim MJ, "Expression of CD95 and CD95L on astrocytes in the CA1 area of the immature rat hippocampus after hypoxia-ischemia injury", Comp Med, 57, pp.581~589 (2007)
- Krägeloh-Mann I, "Bilateral spastic cerebral palsy-MRI pathology and origin. Analysis from a representative series of 56 cases", Dev Med Child Neurol, 37, pp.379~397 (1995)
- Kumral A, "Erythropoietin attenuates lipopolysaccharideinduced white matter injury in the neonatal rat brain", Neonatology, 92, pp.269~278 (2007)
- Lajic S, "Long-term outcome of prenatal treatment of congenital adrenal hyperplasia", Endocr Dev, 13, pp.82~98 (2008)
- Matthews SG, "CRH and AVP-induced changes in synthesis and release of ACTH from the ovine fetal pituitary in vitro: negative influences of cortisol", Endocrine, 6, pp.293~300 (1997)
- Murphy BP, "Impaired cerebral cortical gray matter growth after treatment with dexamethasone for neonatal chronic lung disease", Pediatrics, 107, pp.217~221 (2001)
- Newnham JP, "Should we be prescribing repeated courses of antenatal corticosteroids?", Semin Fetal Neonatal Med, 14, pp.157~163 (2009)
- Nishiyama A, "Normal and reactive NG2+ glial cells are distinct from resting and activated microglia", J Neurosci Res, 48, pp.299~312 (1997)
- Pfeiffer SE, "The oligodendrocyte and its many cellular processes", Trends Cell Biol, 3, pp.191~197 (1993)
- Rajadurai VS, "The use and abuse of steroids in perinatal medicine", Ann Acad Med Singapore, 32, pp.324~334 (2003)
- Rangon CM, "Chronic mild stress during gestation worsens neonatal brain lesions in mice", J Neurosci, 27, pp.7532~7540 (2007)
- Saigal S, "School difficulties at adolescence in a regional cohort of children who were extremely low birth weight", Pediatrics, 105, pp.325~331 (2000)
- Tsuneishi S, "Effects of dexamethasone on the expression of myelin basic protein, proteolipid protein, and glial fibrillary acidic protein genes in developing rat brain", Brain Res Dev Brain Res, 61, pp.117~123 (1991)
- Uehara H, "A new model of white matter injury in neonatal rats with bilateral carotid artery occlusion", Brain Res, 837, pp.213~220 (1999)
- Volpe JJ, "Overview: normal and abnormal human brain development", Ment Retard Dev Disabil Res Rev, 6, pp.1~5 (2000)
- Weichsel ME Jr, "The therapeutic use of glucocorticoid hormones in the perinatal period: potential neurological hazards", Ann Neurol, 2, pp.364~366 (1977)
- Whitaker AH, "Psychiatric outcomes in low-birth-weight children at age 6 years: relation to neonatal cranial ultrasound abnormalities", Arch Gen Psychiatry, 54, pp.847~856 (1997)
- Wilson TT, "Neurodevelopmental and respiratory follow-up results at 7 years for children from the United Kingdom and Ireland enrolled in a randomized trial of early and late postnatal corticosteroid treatment, systemic and inhaled (the Open Study of Early Corticosteroid Treatment)", Pediatrics, 117, pp.2196~2205 (2006)